Miami Cancer Institute Opens Its Doors

Comprehensive cancer center and research facility will be first in South Florida to offer proton therapy.  WHAT: The $430 million, 445,000-square-foot Miami Cancer Institute, part of Baptist Health South Florida, has opened its doors. Led by renowned cancer surgeon and researcher Michael J. Zinner, M.D., the four-story facility located on the Baptist Hospital campus consolidates clinical services, cancer research, and technology platforms under one roof. Miami Cancer Institute provides patients from the community and throughout Latin America and the Caribbean access to some of the most sophisticated treatments in the world as well as clinical trials. It is among a handful of centers in the nation and the first in South Florida to offer proton therapy, which beams radiation directly to a tumor to destroy cancer cells while avoiding healthy tissue.

As Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, Miami Cancer Institute brings unparalleled discoveries and cutting-edge research right here to South Florida.

WHEN/WHERE: Inaugural Event Media Opportunities

  • Thursday, January 26, 2017
  • Miami Cancer Institute
  • 8900 N. Kendall Drive Miami, FL
  • 3:00 p.m. – Private Media Tour of Completed Facility
  • 3:30 p.m. – Opportunity for Soundbites
  • 6:00 p.m. – Private Cocktail Party Begins (800+ attendees expected)
  • 7:00 p.m. – Ribbon Cutting Ceremony & MSK Cancer Alliance Membership Announcement (visual media moment)

Notes: Opportunities for live shots throughout the day, as needed.
Parking available in the Miami Cancer Institute Visitor lot or Valet at the front entrance.
Friday, January 27, 2017
Biltmore Hotel
1200 Anastasia Ave. Coral Gables, FL
7:30 a.m. – 8:30 a.m. Memorial Sloan Kettering Cancer Alliance Symposium

Note: This day-and-a-half symposium will highlight a spectrum of new developments and innovative advances in current oncology practice. Leading experts from Memorial Sloan Kettering Cancer Center and its Cancer Alliance members, including Miami Cancer Institute, will review the technologies and therapeutic approaches to challenging clinical problems, as well as emphasize the supporting science, evidence-based and important research directions.

Remarks:
Michael Zinner, M.D., Founding Chief Executive Officer and Executive Medical Director, Miami Cancer Institute
Richard Barakat, M.D., Deputy Physician-in-Chief of MSK’s Regional Care Network and MSK Cancer Alliance
Jose Baselga, M.D., Ph.D., Physician-in-Chief, Memorial Sloan Kettering Cancer Alliance
*Opportunities for interviews upon request.

MORE: For more information about the Miami Cancer Institute including photos, B-roll and SOTS, visit our newsroom at Newsroom.BaptistHealth.net/MiamiCancerInstitute.

CONTACT: To coordinate coverage plans, please contact Georgi Pipkin via email at This email address is being protected from spambots. You need JavaScript enabled to view it. or by phone at (305)793-9626.

Top